Shuttle Pharmaceuticals Holdings (SHPH) Non Operating Income (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Non Operating Income history runs 6 years deep, the most recent figure standing at $64351.0 for Q1 2026.

• In Q1 2026, Non Operating Income rose 163.23% year-over-year to $64351.0; the TTM figure through Mar 2026 stood at $361272.0 (up 130.0% YoY), while the FY2025 annual figure was $195155.0, up 113.47% from the prior year.
• Non Operating Income was $64351.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from $173340.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $569683.0 in Q1 2023 to a low of -$2.2 million in Q4 2022.
• Historically, Non Operating Income has averaged -$267159.1 across 5 years, with a median of -$176957.0 in 2022.
• The sharpest annual moves came in 2022 and 2023: Non Operating Income plunged 803.47% in 2022, then jumped 1411.33% in 2023.
• A 5-year view of Non Operating Income shows it stood at -$2.2 million in 2022, then surged by 83.65% to -$357676.0 in 2023, then surged by 149.95% to $178659.0 in 2024, then decreased by 2.98% to $173340.0 in 2025, then sank by 62.88% to $64351.0 in 2026.
• The last three Non Operating Income figures came in at $64351.0 (Q1 2026), $173340.0 (Q4 2025), and -$80360.0 (Q3 2025), per Business Quant data.